What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
Barricks v. Wright - Excessive Force Appeal Affirmed
The Fourth Circuit affirmed a district court's decision denying qualified immunity to a sheriff's deputy accused of excessive force. The court found that disputed facts regarding the force used during an arrest necessitate a trial, affirming the appeal denial.
Stephanie Reddin v. Kristi Noem - Employment Discrimination Appeal
The Fourth Circuit affirmed a lower court's dismissal of a former Federal Air Marshal's discrimination lawsuit against the TSA. The court found the plaintiff failed to adequately plead she was a qualified individual capable of performing essential job functions, and that the TSA had provided reasonable accommodations.
Heather Cogdell v. Reliance Standard Life Insurance - ERISA Disability Benefits
The Fourth Circuit Court of Appeals affirmed a lower court's decision in Heather Cogdell v. Reliance Standard Life Insurance Company. The court held that an untimely decision by a plan administrator on an internal appeal of a disability benefits claim, governed by ERISA, does not warrant deferential review.
United States v. Brian K. Griffey - Affirmation of Conviction
The Fourth Circuit Court of Appeals affirmed the conviction of Brian K. Griffey for violating supervised release terms. The court found the 24-month sentence imposed by the district court to be reasonable and not plainly unreasonable.
US v. Rashaun Taylor - Affirmance of conviction in part, dismissal in part
The Fourth Circuit Court of Appeals affirmed in part and dismissed in part the appeal of Rashaun Antonio Taylor. The court vacated Taylor's conviction on Count 3 (use of a firearm during a RICO conspiracy) and its attendant sentence, but otherwise affirmed the district court's denial of his motion for relief.
US v. Antionne Cherry - Sentencing Appeal
The Fourth Circuit Court of Appeals affirmed the sentence of Antionne Cherry, who appealed his conviction for being a felon in possession of a firearm. The court found that any error in calculating Cherry's sentencing guidelines range was harmless.
FDA Warning Letter to Kare Solutions LLC dba Zappy
The FDA issued a warning letter to Kare Solutions LLC dba Zappy for misbranding compounded drug products, including semaglutide, tirzepatide, and liraglutide. The agency found that Zappy's website made false or misleading claims about these products, suggesting they were FDA-approved or compounded by Zappy when they were not.
FDA Warning Letter to Strut Health, LLC
The FDA issued a warning letter to Strut Health, LLC on February 20, 2026, for misbranding compounded semaglutide and tirzepatide products. The company's website allegedly made false or misleading claims about these drugs, violating the Federal Food, Drug, and Cosmetic Act.
FDA Warning Letter to GenoGenix LLC
The FDA issued a warning letter to GenoGenix LLC for serious deficiencies in drug production practices, including failures to meet conditions for outsourcing facilities and insanitary conditions. The company has ceased production and initiated a voluntary recall of drug products.
FDA Warning Letter to Beta Bionics, Inc.
The FDA issued a warning letter to Beta Bionics, Inc. regarding violations of the Quality System Regulation for their iLet Dosing Decision Software and iLet ACE Pump. The letter details failures in corrective and preventive action procedures, including inadequate analysis of complaints leading to serious adverse health outcomes.
Browse by category
US Federal
937 sources
US State
116 sources
US Courts
122 sources
UK
61 sources
EU
53 sources
Canada
23 sources
Courts & Legal
247 sources
Government & Legislation
240 sources
Banking & Finance
211 sources
Trade & Sanctions
122 sources
Healthcare
116 sources
Labor & Employment
110 sources
Energy
101 sources
Environment
82 sources
Pharma & Drug Safety
77 sources
Securities & Markets
73 sources
Agriculture & Food Safety
61 sources
Data Privacy & Cybersecurity
59 sources
Insurance
58 sources
Transportation
56 sources
Tax
54 sources
Defense & National Security
48 sources
Consumer Protection
35 sources
Telecom & Technology
34 sources
Education
20 sources
Housing
15 sources
Immigration
8 sources
Energy & Utilities
1 sources
Browse by agency
HRSA
3 sources
NSF
3 sources
CBSA
3 sources
HHS OIG
3 sources
STB
3 sources
KS Courts
3 sources
SFO
3 sources
VA
3 sources
AMF France
3 sources
FFIEC
3 sources
AL Courts
3 sources
ESMA
3 sources
FEC
3 sources
NY Courts
3 sources
VA Courts
3 sources
EU Council
3 sources
ACPR
3 sources
DOC
3 sources
EIOPA
3 sources
NTSB
3 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.